دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Flashback Foreword: Supervised Risk Predictor of Breast Cancer.
Soldato, Davide MD 1,2,; Miller, Kathy D. MD 3,4,,
doi : 10.1200/JCO.22.02927
Volume 41(26) pgs. 4189-4319 September 10, 2023
JCO Flashback: An Intrinsic Subtype-Based Risk Prediction Model for Early-Stage Breast Cancer (2009).
doi : 10.1200/JCO.23.00900
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes.
Parker, Joel S.; Mullins, Michael; Cheang, Maggie C.U.; Leung, Samuel; Voduc, David; Vickery, Tammi; Davies, Sherri; Fauron, Christiane; He, Xiaping; Hu, Zhiyuan; Quackenbush, John F.; Stijleman, Inge J.; Palazzo, Juan; Marron, J.S.; Nobel, Andrew B.; Mardis, Elaine; Nielsen, Torsten O.; Ellis, Matthew J.; Perou, Charles M.; Bernard, Philip S.
doi : 10.1200/JCO.22.02511
Zipalertinib in EGFR Exon 20-Mutant Non-Small-Cell Lung Cancer: Drug Development in a Rare but Crowded Setting.
Aggarwal, Charu MD, MPH 1,2,3,,; Liu, Stephen V. MD 4,
doi : 10.1200/JCO.23.00958
Debating Sentinel Lymph Node Biopsy for Melanoma in the Modern Adjuvant Era.
Zhang, Xiaoran MD 1,2; Ferris, Laura MD 1,3,; Faries, Mark B. MD 4,5,; Luke, Jason J. MD, FACP 1,6,,
doi : 10.1200/JCO.23.00255
Lazertinib Versus Gefitinib as First-Line Treatment in Patients With EGFR-Mutated Advanced Non-Small-Cell Lung Cancer: Results From LASER301.
Cho, Byoung Chul MD, PhD 1,,; Ahn, Myung-Ju MD, PhD 2,; Kang, Jin Hyoung MD, PhD 3,; Soo, Ross A. MBBS, PhD 4,; Reungwetwattana, Thanyanan MD, MS 5,; Yang, James Chih-Hsin MD, PhD 6,; Cicin, Irfan MD 7,; Kim, Dong-Wan MD, PhD 8,; Wu, Yi-Long MD 9,; Lu, Shun MD, PhD 10,; Lee, Ki Hyeong MD, PhD 11,; Pang, Yong-Kek MD, MCRP 12,; Zimina, Anastasia MD 13; Fong, Chin Heng MD 14; Poddubskaya, Elena MD 15; Sezer, Ahmet MD 16,; How, Soon Hin MMed 17,; Danchaivijitr, Pongwut MD 18,; Kim, YuKyung MD, PhD 19,; Lim, Yeji MS 19,; An, Taewon BS 19,; Lee, Hana MS 19,; Byun, Hae Mi MS 19,; Zaric, Bojan MD, PhD 20,
doi : 10.1200/JCO.23.00515
Safety, Tolerability, and Antitumor Activity of Zipalertinib Among Patients With Non-Small-Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Exon 20 Insertions.
Piotrowska, Zofia MD, MHS 1,,; Tan, Daniel Shao-Weng MBBS, PhD 2,; Smit, Egbert F. MD, PhD 3,; Spira, Alexander I. MD 4,; Soo, Ross A. MBBS, PhD 5,; Nguyen, Danny MD 6,; Lee, Victor Ho-Fun MBBS, MD 7,; Yang, James Chih-Hsin MD, PhD 8,; Velcheti, Vamsidhar MD 9,; Wrangle, John M. MD, MPH 10,; Socinski, Mark A. MD 11,; Koczywas, Marianna MD 6; Janik, John E. MD 12,; Jones, Jeffrey MD, MPH, MBA 12,; Yu, Helena Alexandra MD 13,
doi : 10.1200/JCO.23.00152
Organization of Cancer Specialists in US Physician Practices and Health Systems.
Nguyen, Christina A. SM 1,2; Beaulieu, Nancy D. PhD 2,; Wright, Alexi A. MD, MPH 3,; Cutler, David M. PhD 4,5,; Keating, Nancy L. MD, MPH 2,6; Landrum, Mary Beth PhD 2,
doi : 10.1200/JCO.23.00626
Gilteritinib in Combination With Induction and Consolidation Chemotherapy and as Maintenance Therapy: A Phase IB Study in Patients With Newly Diagnosed AML.
Pratz, Keith W. MD 1,; Cherry, Mohamad MD, MS 2,; Altman, Jessica K. MD 3,; Cooper, Brenda W. MD 4; Podoltsev, Nikolai A. MD, PhD 5,; Cruz, Jose Carlos MD 6; Lin, Tara L. MD 7,; Schiller, Gary J. MD 8,; Jurcic, Joseph G. MD 9,; Asch, Adam MD 10,; Wu, Ruishan MS 11,; Hill, Jason E. PhD 11,; Gill, Stanley C. PhD 11,; James, Angela J. PhD 11,; Rich, Elizabeth Shima MD, PhD 11,; Hasabou, Nahla MD 11,; Perl, Alexander E. MD 1,; Levis, Mark J. MD, PhD 12,,
doi : 10.1200/JCO.22.02721
Severe Hepatopathy in National Wilms Tumor Studies 3-5: Prevalence, Clinical Features, and Outcomes After Reintroduction of Chemotherapy.
Oosterom, Natanja PhD 1; Gooskens, Saskia L.M. PhD 1; Renfro, Lindsay A. PhD 2; Perlman, Elizabeth J. MD 3; van den Heuvel-Eibrink, Marry M. MD, PhD 1; Hamilton, Thomas E. MD 4; Green, Daniel M. MD 5; Grundy, Paul E. MD 6; Daw, Najat C. MD 7,; Geller, James I. MD 8,; Dome, Jeffrey S. MD, PhD 9,; Fernandez, Conrad V. MD 10; Mullen, Elizabeth A. MD 11,
doi : 10.1200/JCO.22.02555
Performance and Operational Feasibility of Epstein-Barr Virus-Based Screening for Detection of Nasopharyngeal Carcinoma: Direct Comparison of Two Alternative Approaches.
Lou, Pei-Jen MD 1; Jacky Lam, W.K. PhD 2,3,4,5,; Hsu, Wan-Lun PhD 6,7; Pfeiffer, Ruth M. PhD 8; Yu, Kelly J. PhD 8; Chan, Charles M.L. PhD 2,3; Lee, Vicky C.T. PhD 2,3; Chen, Tseng-Cheng MD 1; Terng, Shyuang-Der MD 9; Tsou, Yung-An MD 10; Leu, Yi-Shing MD 11; Liao, Li-Jen MD 12; Chang, Yen-Liang MD 13; Chien, Yin-Chu PhD 14; Wang, Cheng-Ping MD 1; Lin, Ching-Yuan MD 9; Hua, Chun-Hung MD 10; Lee, Jehn-Chuan MD 11; Yang, Tsung-Lin MD 1; Hsiao, Chu-Hsing MD 1; Wu, Ming-Shiang MD 1; Tsai, Ming-Hsui MD 10; Cheng, Hung-Chun MD 9; Hildesheim, Allan PhD 8; Chen, Chien-Jen PhD 14; Chan, K.C. Allen PhD 2,3,4,5,,; Liu, Zhiwei PhD 8; on behalf of the GEV-NPC Study Group; GEV-NPC Study Group; Hsu, Wan-Lun; Chien, Yin-Chu; Chen, Chien-Jen; Hildesheim, Allan; Pfeiffer, Ruth M.; Liu, Zhiwei; Yu, Kelly J.; Wang, Cheng-Ping; Yang, Tsung-Lin; Lou, Pei-Jen; Chen, Chun-Nan; Chen, Tseng-Cheng; Lin, Chih-Feng; Jian, James Jer-Min; Cheng, Skye Hongiun; Tsai, Yu-Chen; Chung, Yih-Lin; Wu, Jia-Shing; Liu, Ming-Jiung; Huang, Kuei-Kang; Tsou, Mei-Hua; Chen, Hsin-Hsuan; Lin, Ching-Yuan; Terng, Shyuang-Der; Lin, Fang-Yin; Huang, Hsin-I; Cheng, Hung-Chun; Tsou, Yung-An; Hua, Chun-Hung; Tsai, Ming-Hsui; Leu, Yi-Shing; Lee, Jehn-Chuan; Liao, Li-Jen; Chang, Yen-Liang; Hsiao, Chu-Hsing; Wu, Ming-Shiang
doi : 10.1200/JCO.22.01979
Targeting the Androgen Signaling Axis in Prostate Cancer.
Dai, Charles MD 1,2,3; Dehm, Scott M. PhD 4,5,6,; Sharifi, Nima MD 7,8,9,10,11,
doi : 10.1200/JCO.23.00433
Clinical Multigene Panel Testing Identifies Racial and Ethnic Differences in Germline Pathogenic Variants Among Patients With Early-Onset Colorectal Cancer.
Seagle, Hannah M. BS 1,2; Keller, Samantha R. BA 1,2; Tavtigian, Sean V. PhD 3,; Horton, Carolyn MS 4,; Holowatyj, Andreana N. PhD, MS 1,2,5,6,
doi : 10.1200/JCO.22.02378
Cell-Free Circulating Tumor DNA and Epstein-Barr Virus DNA for Early Diagnosis of Epstein-Barr Virus-Associated Cancers.
Xian, Rena R. MD 1,; Ambinder, Richard F. MD, PhD 2,
doi : 10.1200/JCO.23.00687
Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Systemic Cancer Therapy: ASCO Guideline Update.
Dale, William MD, PhD 1; Klepin, Heidi D. MD, MS 2,; Williams, Grant R. MD, MSPH 3,; Alibhai, Shabbir M.H. MD 4,; Bergerot, Cristiane PhD 5; Brintzenhofeszoc, Karlynn PhD, MSW 6; Hopkins, Judith O. MD 7; Jhawer, Minaxi P. MD 8; Katheria, Vani MS 9; Loh, Kah Poh MBBCh BAO, MS 10,; Lowenstein, Lisa M. PhD 11,; McKoy, June M. MD, MPH, JD, MBA 12,; Noronha, Vanita MD 13,; Phillips, Tanyanika MD 14; Rosko, Ashley E. MD 15,; Ruegg, Tracy PhD, ANP 16,; Schiaffino, Melody K. PhD 17; Simmons, John F. Jr MD 18; Subbiah, Ishwaria MD 19,; Tew, William P. MD 20; Webb, Tracy L. PA-C 21; Whitehead, Mary BFA 22; Somerfield, Mark R. PhD 23; Mohile, Supriya G. MD, MS 10
doi : 10.1200/JCO.23.00933
But Where is My Doctor? The Increasing and Relentless Fragmentation of Oncology Care.
Mintzer, David M. MD 1,
doi : 10.1200/JCO.23.00805
Tai Ji Quan and Fall Risk.
Hu, Ya-Ting BS; Wu, Szu-Yuan MD, PhD; Kao, Yung-Shuo MD
doi : 10.1200/JCO.23.00690
Reply to Y.-T. Hu et al.
Winters-Stone, Kerri M. PhD, FACSM; Roeland, Eric J. MD; Li, Fuzhong PhD; Eckstrom, Elizabeth MD, MPH; Horak, Fay PhD; Dieckmann, Nathan F. PhD; Stoyles, Sydnee A. MS; Luoh, Shiuh-Wen MD
doi : 10.1200/JCO.23.01034
Improving Report of the ADAURA Trial by Distinguishing Treatment-Related Adverse Events From Treatment-Emergent Adverse Events and Assessing Independence of Censoring in Final Disease-Free Survival Analyses.
Wu, Danna MSc; Li, Guo-Fu PhD
doi : 10.1200/JCO.23.00604
Reply to D. Wu et al.
Herbst, Roy S. MD, PhD; Wu, Yi-Long MD; Tsuboi, Masahiro MD, PhD
doi : 10.1200/JCO.23.00887
